Hematology Podcasts Hematology RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Advanced Hodgkin lymphoma: AHL2011 data update from EHA 2018
Dr Olivier Casasnovas, from the Department of Hematology, Dijon, France, gives an update on data from the Phase III AHL2011 study (NCT01358747). Dr Casanovas highlights the outstanding disease control... Author: VJHemOnc Added: 08/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 15, 2018 Category: Cancer & Oncology Source Type: podcasts

Meletios Exciting new therapy for Waldenstrms macroglobulinemia: ibrutinib plus rituximab
Data from the exciting iNNOVATE study (NCT02165397) of ibrutinib plus rituximab for patients with Waldenstrms macroglobulinemia (WM) were presented at the 23rd congress of the European Hematology As... Author: VJHemOnc Added: 08/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 15, 2018 Category: Cancer & Oncology Source Type: podcasts

Exciting new therapy for Waldenstrms macroglobulinemia: ibrutinib plus rituximab
Data from the exciting iNNOVATE study (NCT02165397) of ibrutinib plus rituximab for patients with Waldenstrms macroglobulinemia (WM) were presented at the 23rd congress of the European Hematology As... Author: VJHemOnc Added: 08/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 15, 2018 Category: Cancer & Oncology Source Type: podcasts

Making CAR T-cells happen in Europe
John Gribben, of Barts Cancer Institute, London, UK, discusses making CAR T-cells happen in Europe. This video was recorded at the 23rd congress of the European Hematology Association (EHA) 2018 press... Author: VJHemOnc Added: 08/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 15, 2018 Category: Cancer & Oncology Source Type: podcasts

Big data for HemOnc in Europe: HARMONY
HARMONY is Europe's largest public-private partnership for big data in hematology. Here, Jess Mara Hernndez Rivas, HARMONY Alliance Project Coordinator, from IBSAL, Spain, discuses the alliance and... Author: VJHemOnc Added: 08/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 15, 2018 Category: Cancer & Oncology Source Type: podcasts

Update on bb2121 CAR T-cell product for MM from EHA 2018
Speaking from the 23rd congress of the European Hematology Association (EHA) 2018 press briefing, held in Stockholm, Sweden, Dr Jess Berdeja of the Sarah Cannon Research Institute and Tennessee Oncol... Author: VJHemOnc Added: 08/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 15, 2018 Category: Cancer & Oncology Source Type: podcasts

Iron and inflammation in anemia and sickle cell disease
Speaking from the 23rd congress of the European Hematology Association (EHA) 2018 press briefing, held in Stockholm, Sweden, Dr Francesca Vinchi, of the Iron Research Program, New York Blood Center, N... Author: VJHemOnc Added: 08/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 15, 2018 Category: Cancer & Oncology Source Type: podcasts

Asciminib has the potential to succeed where other TKIs have failed in CML
Tyrosine kinase inhibitors (TKIs) are some of the most successful drugs available for the treatment of a myriad hematological cancers. However, they are not perfect, as patients can relapse or develop... Author: VJHemOnc Added: 08/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 15, 2018 Category: Cancer & Oncology Source Type: podcasts

European-wide MRD screening should be available for all
All types of healthcare, including measurable residual disease (MRD) testing should be available to everyone throughout Europe. Speaking from the 2018 European School of Hematology (ESH) Clinical Upda... Author: VJHemOnc Added: 08/13/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 13, 2018 Category: Cancer & Oncology Source Type: podcasts

The ALL frontier: should T-ALL be classed as a different disease?
Speaking from the 2018 European School of Hematology (ESH) Clinical Updates on Acute Leukemias, Elizabeth Macintyre, MD, PhD, of the Hpital Necker-Enfants Malades, Paris, France, explains why she bel... Author: VJHemOnc Added: 08/13/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 13, 2018 Category: Cancer & Oncology Source Type: podcasts

Key points in patient support across hematological oncology
Felice Bombaci, from the AIL patient group for chronic myeloid leukemia (CML), Rome, Italy, discusses some important key topics in patient support in Italy for hematological malignancies. He speaks ab... Author: VJHemOnc Added: 08/13/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 13, 2018 Category: Cancer & Oncology Source Type: podcasts

Using MRD to guide MM treatment
Measurable residual disease (MRD) analysis is becoming increasingly commonplace as a prognostic indicator and tool for guiding the management of multiple myeloma (MM) and other hematological malignanc... Author: VJHemOnc Added: 08/10/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 10, 2018 Category: Cancer & Oncology Source Type: podcasts

Using biomarkers and genomics to inform treatment strategy in ALL
Speaking from the 23rd Congress of the European Hematology Association (EHA) 2018, in Stockholm, Sweden, Thomas Alexander, MD, PhD, of the University of North Carolina School of Medicine, Chapel Hill,... Author: VJHemOnc Added: 08/10/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 10, 2018 Category: Cancer & Oncology Source Type: podcasts

Positive results for acalabrutinib in Waldenstrm's macroglobulinemia
BTK inhibition is a popular avenue of treatment research in Waldenstrm's macroglobulinemia (WM). In this video, recorded at the 23rd Congress of the European Hematology Association (EHA) 2018, in Sto... Author: VJHemOnc Added: 08/10/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 10, 2018 Category: Cancer & Oncology Source Type: podcasts

Early MRD negativity predicts depth of response to CAR T-cells in R/R MM
Nikhil Munshi, MD, of the Dana-Farber Cancer Institute, Boston, MA, presented results from the CRB-401 trial (NCT02658929) at the 23rd Congress of European Hematology Association (EHA) 2018, held in S... Author: VJHemOnc Added: 08/10/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 10, 2018 Category: Cancer & Oncology Source Type: podcasts